Mycronic AB (publ) (STO:MYCR)
Sweden flag Sweden · Delayed Price · Currency is SEK
342.80
-4.80 (-1.38%)
Jul 24, 2026, 5:29 PM CET

Mycronic AB Earnings Call Transcripts

Fiscal Year 2026

  • Record order intake and strong sales growth were driven by robust demand across all divisions, especially Global Technologies. EBIT margin remained high at 29%, and the full-year outlook was raised to SEK 9.25 billion, supported by capacity expansions and ongoing restructuring.

  • Q1 delivered record sales and EBIT, driven by strong demand in High Volume and Global Technologies, leading to an upgraded 2026 sales outlook. Pattern Generators saw robust sales but lower order intake, while PCB Assembly Solutions remained weak. AI and OLED trends continue to support growth.

Fiscal Year 2025

  • Order intake declined 19% year-over-year, but sales remained flat as strong growth in Global Technologies offset declines elsewhere. EBIT margin was 17% for the quarter, with a stable backlog and continued R&D investment, while the outlook targets SEK 8.25 billion in sales for the year.

  • Order intake surged 67% year-over-year, led by Pattern Generators and Global Technologies, while sales dipped 4% and EBIT margin fell to 15% due to product mix. Backlog and cash remain strong, with continued M&A activity and a positive full-year outlook.

  • Q2 saw 35% sales growth and a 27% EBIT margin, with strong performance in Pattern Generators and High Volume, but order intake declined due to no new system orders. Three acquisitions and a share split were completed, and full-year sales guidance was reaffirmed at SEK 7.5 billion.

  • Q1 delivered record sales and EBIT, driven by strong Pattern Generators and High Volume performance, while High Flex lagged due to weak European demand and tariffs. Guidance was revised to SEK 7–7.5 billion amid increased uncertainty from tariffs and currency.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020